World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   1021 records for 204 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of RegistrationResults available
AuthorisedYesEUCTR2016-004046-28-HR
A clinical study to assess the long-term safety and efficacy of Orelvo (voclosporin) compared with placebo in subjects with active lupus nephritis (LN)
13/04/2018 
AuthorisedYesEUCTR2017-003966-29-AT
A clinical trial to assess 2 different doses of BCX7353 compared to placebo as an oral treatment for the prevention of attacks in people with HAE 26/03/2018 
Not AvailableYesEUCTR2017-003966-29-CZ
A clinical trial to assess 2 different doses of BCX7353 compared to placebo as an oral treatment for the prevention of attacks in people with HAE
26/03/2018 
Not recruitingYesNCT03466411
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
08/03/2018 
RecruitingYesNCT03472040
A Long Term Safety Study of BCX7353 in Hereditary Angioedema
27/02/2018 
AuthorisedYesEUCTR2017-001834-25-SE
To compare two medication therapies to prevent thrombus (blood cloth) formation following the successful treatment of a coronary heart disease with expansion of coronary stent (metallic tube) covered with medication (Drug Eluting Stent-DES): a shortened versus a prolonged dual antiplatelet therapy (DAPT, drugs that inhibit bloodplatelets, blood cells involved in the thrombus formation process).
01/11/2017 
AuthorisedYesEUCTR2017-003281-27-DE
Long Term Safety Study of BCX7353 in HAE
Recruitment statusMain IDPublic titleDate of registrationResults available
AuthorisedEUCTR2017-003281-27-HU Long Term Safety Study of BCX7353 in HAE 17/11/2017 
AuthorisedEUCTR2017-003281-27-AT Long Term Safety Study of BCX7353 in HAE 28/11/2017 
AuthorisedEUCTR2017-003281-27-ES Long Term Safety Study of BCX7353 in HAE 14/12/2017Yes
AuthorisedEUCTR2017-003281-27-DK Long Term Safety Study of BCX7353 in HAE 17/11/2017Yes
AuthorisedEUCTR2017-003281-27-SK Long Term Safety Study of BCX7353 in HAE 07/03/2018 
16/10/2017 
Not RecruitingYesDRKS00012745
The Psychosocial Burden of Skin Disease: Stigmatization and body image. An international multicenter study
06/10/2017 
AuthorisedYesEUCTR2017-002644-32-LV
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Recruitment statusMain IDPublic titleDate of registrationResults available
AuthorisedEUCTR2017-002644-32-HU Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk 09/10/2017 
AuthorisedEUCTR2017-002644-32-LT Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk 26/10/2017 
AuthorisedEUCTR2017-002644-32-EE Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk 02/11/2017 
AuthorisedEUCTR2017-002644-32-NL Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk 25/10/2017Yes
AuthorisedEUCTR2017-002644-32-DK Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk 25/10/2017Yes
AuthorisedEUCTR2017-002644-32-PT Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk 21/11/2017 
RecruitingNCT03315143 Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk 16/10/2017 
AuthorisedEUCTR2017-002644-32-BG Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk 05/01/2018 
AuthorisedEUCTR2017-002644-32-SE Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk 12/10/2017 
AuthorisedEUCTR2017-002644-32-GR Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk 28/12/2017 
04/10/2017 
RecruitingYesNCT03303313
A Study of an Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic Syndrome
25/09/2017 
      
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history